Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease

Luca Valenti, Anna Ludovica Fracanzani, Paola Dongiovanni, Gennaro Santorelli, Adriana Branchi, Emanuela Taioli, Gemino Fiorelli, Silvia Fargion

Research output: Contribution to journalArticle

Abstract

Background & Aims: Nonalcoholic fatty liver disease, which can range from fatty liver alone to nonalcoholic steatohepatitis and cirrhosis, is related to insulin resistance. Tumor necrosis factor α (TNF-α) may induce insulin resistance, and polymorphisms of its promoter have been associated with an increased release of this cytokine. We analyzed (1) the prevalence of insulin resistance, (2) the prevalence of the 238 and 308 TNF-α polymorphisms, and (3) the relationship among TNF-α polymorphisms, insulin resistance, and the occurrence of steatohepatitis in 99 patients with nonalcoholic fatty liver diagnosed by ultrasonography and confirmed by histologic analysis in the 53 who underwent biopsy. Methods: Insulin resistance was evaluated by the homeostatic metabolic assessment insulin resistance indices and TNF-α polymorphisms by polymerase chain reaction and restriction fragment length polymorphism analysis. Results: Insulin resistance was detected in almost all of the patients and was more severe in those with steatohepatitis. The prevalence of the 238, but not of the 308, TNF-α polymorphism was higher in subjects with nonalcoholic fatty liver than in controls (31% vs. 15%; P <0.0001), and patients positive for TNF-α polymorphisms had higher insulin resistance indices, a higher prevalence of impaired glucose tolerance, and a lower number of associated risk factors for steatosis. Conclusions: TNF-α polymorphisms could represent a susceptibility genotype for insulin resistance, nonalcoholic fatty liver, and steatohepatitis.

Original languageEnglish
Pages (from-to)274-280
Number of pages7
JournalGastroenterology
Volume122
Issue number2
Publication statusPublished - 2002

Fingerprint

Insulin Resistance
Tumor Necrosis Factor-alpha
Fatty Liver
Non-alcoholic Fatty Liver Disease
Glucose Intolerance
Restriction Fragment Length Polymorphisms
Ultrasonography
Fibrosis
Genotype
Cytokines
Biopsy
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease. / Valenti, Luca; Fracanzani, Anna Ludovica; Dongiovanni, Paola; Santorelli, Gennaro; Branchi, Adriana; Taioli, Emanuela; Fiorelli, Gemino; Fargion, Silvia.

In: Gastroenterology, Vol. 122, No. 2, 2002, p. 274-280.

Research output: Contribution to journalArticle

@article{d325d2ed2b9f4638b2acf2ba065cd38c,
title = "Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease",
abstract = "Background & Aims: Nonalcoholic fatty liver disease, which can range from fatty liver alone to nonalcoholic steatohepatitis and cirrhosis, is related to insulin resistance. Tumor necrosis factor α (TNF-α) may induce insulin resistance, and polymorphisms of its promoter have been associated with an increased release of this cytokine. We analyzed (1) the prevalence of insulin resistance, (2) the prevalence of the 238 and 308 TNF-α polymorphisms, and (3) the relationship among TNF-α polymorphisms, insulin resistance, and the occurrence of steatohepatitis in 99 patients with nonalcoholic fatty liver diagnosed by ultrasonography and confirmed by histologic analysis in the 53 who underwent biopsy. Methods: Insulin resistance was evaluated by the homeostatic metabolic assessment insulin resistance indices and TNF-α polymorphisms by polymerase chain reaction and restriction fragment length polymorphism analysis. Results: Insulin resistance was detected in almost all of the patients and was more severe in those with steatohepatitis. The prevalence of the 238, but not of the 308, TNF-α polymorphism was higher in subjects with nonalcoholic fatty liver than in controls (31{\%} vs. 15{\%}; P <0.0001), and patients positive for TNF-α polymorphisms had higher insulin resistance indices, a higher prevalence of impaired glucose tolerance, and a lower number of associated risk factors for steatosis. Conclusions: TNF-α polymorphisms could represent a susceptibility genotype for insulin resistance, nonalcoholic fatty liver, and steatohepatitis.",
author = "Luca Valenti and Fracanzani, {Anna Ludovica} and Paola Dongiovanni and Gennaro Santorelli and Adriana Branchi and Emanuela Taioli and Gemino Fiorelli and Silvia Fargion",
year = "2002",
language = "English",
volume = "122",
pages = "274--280",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease

AU - Valenti, Luca

AU - Fracanzani, Anna Ludovica

AU - Dongiovanni, Paola

AU - Santorelli, Gennaro

AU - Branchi, Adriana

AU - Taioli, Emanuela

AU - Fiorelli, Gemino

AU - Fargion, Silvia

PY - 2002

Y1 - 2002

N2 - Background & Aims: Nonalcoholic fatty liver disease, which can range from fatty liver alone to nonalcoholic steatohepatitis and cirrhosis, is related to insulin resistance. Tumor necrosis factor α (TNF-α) may induce insulin resistance, and polymorphisms of its promoter have been associated with an increased release of this cytokine. We analyzed (1) the prevalence of insulin resistance, (2) the prevalence of the 238 and 308 TNF-α polymorphisms, and (3) the relationship among TNF-α polymorphisms, insulin resistance, and the occurrence of steatohepatitis in 99 patients with nonalcoholic fatty liver diagnosed by ultrasonography and confirmed by histologic analysis in the 53 who underwent biopsy. Methods: Insulin resistance was evaluated by the homeostatic metabolic assessment insulin resistance indices and TNF-α polymorphisms by polymerase chain reaction and restriction fragment length polymorphism analysis. Results: Insulin resistance was detected in almost all of the patients and was more severe in those with steatohepatitis. The prevalence of the 238, but not of the 308, TNF-α polymorphism was higher in subjects with nonalcoholic fatty liver than in controls (31% vs. 15%; P <0.0001), and patients positive for TNF-α polymorphisms had higher insulin resistance indices, a higher prevalence of impaired glucose tolerance, and a lower number of associated risk factors for steatosis. Conclusions: TNF-α polymorphisms could represent a susceptibility genotype for insulin resistance, nonalcoholic fatty liver, and steatohepatitis.

AB - Background & Aims: Nonalcoholic fatty liver disease, which can range from fatty liver alone to nonalcoholic steatohepatitis and cirrhosis, is related to insulin resistance. Tumor necrosis factor α (TNF-α) may induce insulin resistance, and polymorphisms of its promoter have been associated with an increased release of this cytokine. We analyzed (1) the prevalence of insulin resistance, (2) the prevalence of the 238 and 308 TNF-α polymorphisms, and (3) the relationship among TNF-α polymorphisms, insulin resistance, and the occurrence of steatohepatitis in 99 patients with nonalcoholic fatty liver diagnosed by ultrasonography and confirmed by histologic analysis in the 53 who underwent biopsy. Methods: Insulin resistance was evaluated by the homeostatic metabolic assessment insulin resistance indices and TNF-α polymorphisms by polymerase chain reaction and restriction fragment length polymorphism analysis. Results: Insulin resistance was detected in almost all of the patients and was more severe in those with steatohepatitis. The prevalence of the 238, but not of the 308, TNF-α polymorphism was higher in subjects with nonalcoholic fatty liver than in controls (31% vs. 15%; P <0.0001), and patients positive for TNF-α polymorphisms had higher insulin resistance indices, a higher prevalence of impaired glucose tolerance, and a lower number of associated risk factors for steatosis. Conclusions: TNF-α polymorphisms could represent a susceptibility genotype for insulin resistance, nonalcoholic fatty liver, and steatohepatitis.

UR - http://www.scopus.com/inward/record.url?scp=0036165809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036165809&partnerID=8YFLogxK

M3 - Article

C2 - 11832442

AN - SCOPUS:0036165809

VL - 122

SP - 274

EP - 280

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 2

ER -